Skip to main content

Clifford Chance

Clifford Chance
All
Briefings

Briefings

In this section

Australian competition regulator brings proceedings for alleged misuse of market power in pharmaceutical industry

26 February 2014

In recent years, the Australian Competition and Consumer Commission (ACCC) has vigorously enforced its competition laws in cases of alleged misuse of market power, cartel conduct and anti-competitive agreements.  Continuing this trend, in February 2014 the ACCC filed civil proceedings in a superior Australian court against multinational pharmaceutical company Pfizer for alleged misuse of market power and exclusive dealing in relation to its anti-cholesterol drug Lipitor shortly before patent expiry. Pfizer strenuously denies that its conduct contravened the law.

Download PDF
  • Share on Twitter
  • Share on LinkedIn
  • Share via email
Back to top

Toolkits & Client Log-in